Insider Transactions

ZIMMER BIOMET HOLDINGS, INC. (ZBH) Insider Transactions

Over the last 12 months, 18 ZIMMER BIOMET HOLDINGS, INC. (ZBH) insiders filed 177 SEC Form 4 transactions — $0 in open-market purchases ( 0 distinct buyers) and $1.2M in open-market sales. 0% of all transactions were executed under a pre-scheduled Rule 10b5-1 trading plan.

Recent Form 4 Filings Most recent 50 of 177 (1-year window)

Each row is a single Form 4 filing event for ZBH, sourced directly from SEC EDGAR. The Type column classifies the SEC transaction code into Buy / Sell / Grant / Exercise / Other; the 10b5-1 badge marks trades executed under a pre-scheduled SEC Rule 10b5-1 plan.

Date Insider Title Type SEC Code Value Shares Price
2026-06-01 Noor Jehanzeb See remarks below. Grant A $0 1,857 $0.00
2026-05-29 Yi Sang Group President, Asia Pacific Sell S $347.1K 4,200 $82.64
2026-05-29 Yi Sang Group President, Asia Pacific Sell S $66.1K 800 $82.66
2026-05-22 Farrell Michael J. Grant A $0 875 $0.00
2026-05-22 Farrell Michael J. Grant A $0 1,517 $0.00
2026-05-22 BERNARD BETSY J Grant A $0 875 $0.00
2026-05-22 BERNARD BETSY J Grant A $0 1,517 $0.00
2026-05-22 Hilado Maria Teresa Grant A $0 875 $0.00
2026-05-22 Hilado Maria Teresa Grant A $0 1,517 $0.00
2026-05-22 Shapiro Louis Grant A $0 875 $0.00
2026-05-22 Shapiro Louis Grant A $0 1,517 $0.00
2026-05-22 Kurdikar Devdatt Grant A $0 875 $0.00
2026-05-22 Kurdikar Devdatt Grant A $0 1,517 $0.00
2026-05-22 Kolli Sreelakshmi Grant A $0 875 $0.00
2026-05-22 Kolli Sreelakshmi Grant A $0 1,517 $0.00
2026-05-22 Jafry Syed A. Grant A $0 875 $0.00
2026-05-22 Jafry Syed A. Grant A $0 1,517 $0.00
2026-05-22 HIGGINS ARTHUR J Grant A $0 875 $0.00
2026-05-22 HIGGINS ARTHUR J Grant A $0 1,517 $0.00
2026-05-22 HAGEMANN ROBERT Grant A $0 875 $0.00
2026-05-22 HAGEMANN ROBERT Grant A $0 1,517 $0.00
2026-05-01 Stellato Paul A VP, Controller, CAO Grant A $0 9,232 $0.00
2026-04-01 Noor Jehanzeb See remarks below. Exercise M $0 6,626 $0.00
2026-04-01 Noor Jehanzeb See remarks below. Exercise M $0 6,626 $0.00
2026-04-01 Noor Jehanzeb See remarks below. Other F $152.1K 1,677 $90.67
2026-03-31 Jafry Syed A. Grant A $0 182 $0.00
2026-03-31 Kolli Sreelakshmi Grant A $0 175 $0.00
2026-03-31 Shapiro Louis Grant A $0 154 $0.00
2026-03-31 Hilado Maria Teresa Grant A $0 379 $0.00
2026-03-31 HIGGINS ARTHUR J Grant A $0 309 $0.00
2026-03-31 Kurdikar Devdatt Grant A $0 154 $0.00
2026-03-31 HAGEMANN ROBERT Grant A $0 309 $0.00
2026-03-31 Farrell Michael J. Grant A $0 421 $0.00
2026-03-12 Winkler Lori SVP and CHRO Sell $250.8K 2,650 $94.66
2026-03-06 Upadhyay Suketu Exec VP, CFO Grant $0 10,217 $0.00
2026-03-06 Upadhyay Suketu Exec VP, CFO Grant $420.8K 4,547 $92.54
2026-03-06 Upadhyay Suketu Exec VP, CFO Grant $0 4,559 $0.00
2026-03-06 Upadhyay Suketu Exec VP, CFO Grant $187.8K 2,029 $92.54
2026-03-06 Upadhyay Suketu Exec VP, CFO Grant $0 10,217 $0.00
2026-03-06 Upadhyay Suketu Exec VP, CFO Grant $0 4,559 $0.00
2026-03-06 VAN ZUILEN WILFRED Group Pres, EMEA Grant $0 4,843 $0.00
2026-03-06 VAN ZUILEN WILFRED Group Pres, EMEA Grant $116.6K 1,260 $92.54
2026-03-06 VAN ZUILEN WILFRED Group Pres, EMEA Grant $0 2,161 $0.00
2026-03-06 VAN ZUILEN WILFRED Group Pres, EMEA Grant $52.0K 562 $92.54
2026-03-06 VAN ZUILEN WILFRED Group Pres, EMEA Grant $0 4,843 $0.00
2026-03-06 VAN ZUILEN WILFRED Group Pres, EMEA Grant $0 2,161 $0.00
2026-03-06 Winkler Lori SVP and CHRO Grant $0 3,935 $0.00
2026-03-06 Winkler Lori SVP and CHRO Grant $143.3K 1,549 $92.54
2026-03-06 Winkler Lori SVP and CHRO Grant $0 1,699 $0.00
2026-03-06 Winkler Lori SVP and CHRO Grant $58.2K 629 $92.54

Showing the most recent 50 of 177 transactions. For the full 1-year history with sorting, filtering, and cross-ticker industry context, open the full insider transactions drilldown.

Methodology & FAQ

How We Track ZBH Insider Transactions

Form 4 disclosures are sourced directly from SEC EDGAR and re-ingested on every pipeline cycle. A complete description of transaction-code handling, the open-market vs grant distinction, and the Rule 10b5-1 plan-reference heuristic is documented in the Methodology.

What is an SEC Form 4 filing for ZIMMER BIOMET HOLDINGS, INC.?

Form 4 is a transaction-level disclosure that corporate insiders — officers, directors, and beneficial owners of more than 10% of a registered class of equity securities — must file with the SEC within two business days of any change in their beneficial ownership of ZIMMER BIOMET HOLDINGS, INC. (ZBH) shares.

What is a Rule 10b5-1 trading plan?

Rule 10b5-1 is an SEC rule that lets insiders schedule trades in advance under a written plan, providing an affirmative defense against insider-trading allegations as long as the plan was adopted in good faith and not while in possession of material non-public information. Form 4 rows marked "10b5-1" on this page indicate the underlying trade was executed under such a plan; rows without the badge are discretionary or did not reference a plan in the Form 4 footnotes.

How is "insider buying" different from a stock grant or option exercise?

An insider buy (SEC transaction code P) is an open-market purchase of ZIMMER BIOMET HOLDINGS, INC. (ZBH) stock executed at the prevailing market price using the insider's personal capital. Stock grants (code A) and option exercises (code M) are compensation events, not directional trades; they are tracked separately and excluded from the "conviction" signal because they are not discretionary purchases.

How recent is the data?

Form 4 transactions are typically reported within two business days of execution. Pactolio re-ingests the EDGAR feed on a nightly cycle and reflects new filings on the next ingest run, typically within 24 hours of EDGAR acceptance. The table on this page covers the most recent 1-year window.